Report Overview
Monoclonal antibody treatment is a type of targeted therapy that uses specific antibodies to identify and attack cancer cells or other diseased cells in the body.
This report provides a deep insight into the global Monoclonal Antibody Treatment market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Monoclonal Antibody Treatment Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Monoclonal Antibody Treatment market in any manner.
Global Monoclonal Antibody Treatment Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Pfizer
Bayer
Sanofi
Merck
GlaxoSmithKline
Roche
Novartis
AbbVie
Shanghai Junshi Biosciences Co.,Ltd
Innovent Biologics
Jiangsu Hengrui Medicine Co.,Ltd.
BeiGene, Ltd.
Grand Pharmaceutical (China) Co., Ltd
Henlius
Market Segmentation (by Type)
Cancer
Autoimmune Diseases
Exogenous Infection
Hematological Diseases
Market Segmentation (by Application)
Hospitals
Clinics
Others
Geographic Segmentation
? North America (USA, Canada, Mexico)
? Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
? Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
? South America (Brazil, Argentina, Columbia, Rest of South America)
? The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
? Industry drivers, restraints, and opportunities covered in the study
? Neutral perspective on the market performance
? Recent industry trends and developments
? Competitive landscape & strategies of key players
? Potential & niche segments and regions exhibiting promising growth covered
? Historical, current, and projected market size, in terms of value
? In-depth analysis of the Monoclonal Antibody Treatment Market
? Overview of the regional outlook of the Monoclonal Antibody Treatment Market:
Key Reasons to Buy this Report:
? Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
? This enables you to anticipate market changes to remain ahead of your competitors
? You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
? The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
? Provision of market value (USD Billion) data for each segment and sub-segment
? Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
? Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
? Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
? Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
? The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
? Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
? Provides insight into the market through Value Chain
? Market dynamics scenario, along with growth opportunities of the market in the years to come
? 6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Monoclonal Antibody Treatment Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
TABLE OF CONTENTS
Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Monoclonal Antibody Treatment
1.2 Key Market Segments
1.2.1 Monoclonal Antibody Treatment Segment by Type
1.2.2 Monoclonal Antibody Treatment Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Monoclonal Antibody Treatment Market Overview
2.1 Global Market Overview
2.1.1 Global Monoclonal Antibody Treatment Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Monoclonal Antibody Treatment Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Monoclonal Antibody Treatment Market Competitive Landscape
3.1 Global Monoclonal Antibody Treatment Sales by Manufacturers (2019-2024)
3.2 Global Monoclonal Antibody Treatment Revenue Market Share by Manufacturers (2019-2024)
3.3 Monoclonal Antibody Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Monoclonal Antibody Treatment Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Monoclonal Antibody Treatment Sales Sites, Area Served, Product Type
3.6 Monoclonal Antibody Treatment Market Competitive Situation and Trends
3.6.1 Monoclonal Antibody Treatment Market Concentration Rate
3.6.2 Global 5 and 10 Largest Monoclonal Antibody Treatment Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Monoclonal Antibody Treatment Industry Chain Analysis
4.1 Monoclonal Antibody Treatment Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Monoclonal Antibody Treatment Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Monoclonal Antibody Treatment Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Monoclonal Antibody Treatment Sales Market Share by Type (2019-2024)
6.3 Global Monoclonal Antibody Treatment Market Size Market Share by Type (2019-2024)
6.4 Global Monoclonal Antibody Treatment Price by Type (2019-2024)
7 Monoclonal Antibody Treatment Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Monoclonal Antibody Treatment Market Sales by Application (2019-2024)
7.3 Global Monoclonal Antibody Treatment Market Size (M USD) by Application (2019-2024)
7.4 Global Monoclonal Antibody Treatment Sales Growth Rate by Application (2019-2024)
8 Monoclonal Antibody Treatment Market Segmentation by Region
8.1 Global Monoclonal Antibody Treatment Sales by Region
8.1.1 Global Monoclonal Antibody Treatment Sales by Region
8.1.2 Global Monoclonal Antibody Treatment Sales Market Share by Region
8.2 North America
8.2.1 North America Monoclonal Antibody Treatment Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Monoclonal Antibody Treatment Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Monoclonal Antibody Treatment Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Monoclonal Antibody Treatment Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Monoclonal Antibody Treatment Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 Pfizer
9.1.1 Pfizer Monoclonal Antibody Treatment Basic Information
9.1.2 Pfizer Monoclonal Antibody Treatment Product Overview
9.1.3 Pfizer Monoclonal Antibody Treatment Product Market Performance
9.1.4 Pfizer Business Overview
9.1.5 Pfizer Monoclonal Antibody Treatment SWOT Analysis
9.1.6 Pfizer Recent Developments
9.2 Bayer
9.2.1 Bayer Monoclonal Antibody Treatment Basic Information
9.2.2 Bayer Monoclonal Antibody Treatment Product Overview
9.2.3 Bayer Monoclonal Antibody Treatment Product Market Performance
9.2.4 Bayer Business Overview
9.2.5 Bayer Monoclonal Antibody Treatment SWOT Analysis
9.2.6 Bayer Recent Developments
9.3 Sanofi
9.3.1 Sanofi Monoclonal Antibody Treatment Basic Information
9.3.2 Sanofi Monoclonal Antibody Treatment Product Overview
9.3.3 Sanofi Monoclonal Antibody Treatment Product Market Performance
9.3.4 Sanofi Monoclonal Antibody Treatment SWOT Analysis
9.3.5 Sanofi Business Overview
9.3.6 Sanofi Recent Developments
9.4 Merck
9.4.1 Merck Monoclonal Antibody Treatment Basic Information
9.4.2 Merck Monoclonal Antibody Treatment Product Overview
9.4.3 Merck Monoclonal Antibody Treatment Product Market Performance
9.4.4 Merck Business Overview
9.4.5 Merck Recent Developments
9.5 GlaxoSmithKline
9.5.1 GlaxoSmithKline Monoclonal Antibody Treatment Basic Information
9.5.2 GlaxoSmithKline Monoclonal Antibody Treatment Product Overview
9.5.3 GlaxoSmithKline Monoclonal Antibody Treatment Product Market Performance
9.5.4 GlaxoSmithKline Business Overview
9.5.5 GlaxoSmithKline Recent Developments
9.6 Roche
9.6.1 Roche Monoclonal Antibody Treatment Basic Information
9.6.2 Roche Monoclonal Antibody Treatment Product Overview
9.6.3 Roche Monoclonal Antibody Treatment Product Market Performance
9.6.4 Roche Business Overview
9.6.5 Roche Recent Developments
9.7 Novartis
9.7.1 Novartis Monoclonal Antibody Treatment Basic Information
9.7.2 Novartis Monoclonal Antibody Treatment Product Overview
9.7.3 Novartis Monoclonal Antibody Treatment Product Market Performance
9.7.4 Novartis Business Overview
9.7.5 Novartis Recent Developments
9.8 AbbVie
9.8.1 AbbVie Monoclonal Antibody Treatment Basic Information
9.8.2 AbbVie Monoclonal Antibody Treatment Product Overview
9.8.3 AbbVie Monoclonal Antibody Treatment Product Market Performance
9.8.4 AbbVie Business Overview
9.8.5 AbbVie Recent Developments
9.9 Shanghai Junshi Biosciences Co.,Ltd
9.9.1 Shanghai Junshi Biosciences Co.,Ltd Monoclonal Antibody Treatment Basic Information
9.9.2 Shanghai Junshi Biosciences Co.,Ltd Monoclonal Antibody Treatment Product Overview
9.9.3 Shanghai Junshi Biosciences Co.,Ltd Monoclonal Antibody Treatment Product Market Performance
9.9.4 Shanghai Junshi Biosciences Co.,Ltd Business Overview
9.9.5 Shanghai Junshi Biosciences Co.,Ltd Recent Developments
9.10 Innovent Biologics
9.10.1 Innovent Biologics Monoclonal Antibody Treatment Basic Information
9.10.2 Innovent Biologics Monoclonal Antibody Treatment Product Overview
9.10.3 Innovent Biologics Monoclonal Antibody Treatment Product Market Performance
9.10.4 Innovent Biologics Business Overview
9.10.5 Innovent Biologics Recent Developments
9.11 Jiangsu Hengrui Medicine Co.,Ltd.
9.11.1 Jiangsu Hengrui Medicine Co.,Ltd. Monoclonal Antibody Treatment Basic Information
9.11.2 Jiangsu Hengrui Medicine Co.,Ltd. Monoclonal Antibody Treatment Product Overview
9.11.3 Jiangsu Hengrui Medicine Co.,Ltd. Monoclonal Antibody Treatment Product Market Performance
9.11.4 Jiangsu Hengrui Medicine Co.,Ltd. Business Overview
9.11.5 Jiangsu Hengrui Medicine Co.,Ltd. Recent Developments
9.12 BeiGene, Ltd.
9.12.1 BeiGene, Ltd. Monoclonal Antibody Treatment Basic Information
9.12.2 BeiGene, Ltd. Monoclonal Antibody Treatment Product Overview
9.12.3 BeiGene, Ltd. Monoclonal Antibody Treatment Product Market Performance
9.12.4 BeiGene, Ltd. Business Overview
9.12.5 BeiGene, Ltd. Recent Developments
9.13 Grand Pharmaceutical (China) Co., Ltd
9.13.1 Grand Pharmaceutical (China) Co., Ltd Monoclonal Antibody Treatment Basic Information
9.13.2 Grand Pharmaceutical (China) Co., Ltd Monoclonal Antibody Treatment Product Overview
9.13.3 Grand Pharmaceutical (China) Co., Ltd Monoclonal Antibody Treatment Product Market Performance
9.13.4 Grand Pharmaceutical (China) Co., Ltd Business Overview
9.13.5 Grand Pharmaceutical (China) Co., Ltd Recent Developments
9.14 Henlius
9.14.1 Henlius Monoclonal Antibody Treatment Basic Information
9.14.2 Henlius Monoclonal Antibody Treatment Product Overview
9.14.3 Henlius Monoclonal Antibody Treatment Product Market Performance
9.14.4 Henlius Business Overview
9.14.5 Henlius Recent Developments
10 Monoclonal Antibody Treatment Market Forecast by Region
10.1 Global Monoclonal Antibody Treatment Market Size Forecast
10.2 Global Monoclonal Antibody Treatment Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Monoclonal Antibody Treatment Market Size Forecast by Country
10.2.3 Asia Pacific Monoclonal Antibody Treatment Market Size Forecast by Region
10.2.4 South America Monoclonal Antibody Treatment Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Monoclonal Antibody Treatment by Country
11 Forecast Market by Type and by Application (2025-2030)
11.1 Global Monoclonal Antibody Treatment Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Monoclonal Antibody Treatment by Type (2025-2030)
11.1.2 Global Monoclonal Antibody Treatment Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Monoclonal Antibody Treatment by Type (2025-2030)
11.2 Global Monoclonal Antibody Treatment Market Forecast by Application (2025-2030)
11.2.1 Global Monoclonal Antibody Treatment Sales (Kilotons) Forecast by Application
11.2.2 Global Monoclonal Antibody Treatment Market Size (M USD) Forecast by Application (2025-2030)
12 Conclusion and Key Findings
LIST OF TABLES & FIGURES
List of Tables
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Monoclonal Antibody Treatment Market Size Comparison by Region (M USD)
Table 5. Global Monoclonal Antibody Treatment Sales (Kilotons) by Manufacturers (2019-2024)
Table 6. Global Monoclonal Antibody Treatment Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Monoclonal Antibody Treatment Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Monoclonal Antibody Treatment Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Monoclonal Antibody Treatment as of 2022)
Table 10. Global Market Monoclonal Antibody Treatment Average Price (USD/Ton) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Monoclonal Antibody Treatment Sales Sites and Area Served
Table 12. Manufacturers Monoclonal Antibody Treatment Product Type
Table 13. Global Monoclonal Antibody Treatment Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Monoclonal Antibody Treatment
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Monoclonal Antibody Treatment Market Challenges
Table 22. Global Monoclonal Antibody Treatment Sales by Type (Kilotons)
Table 23. Global Monoclonal Antibody Treatment Market Size by Type (M USD)
Table 24. Global Monoclonal Antibody Treatment Sales (Kilotons) by Type (2019-2024)
Table 25. Global Monoclonal Antibody Treatment Sales Market Share by Type (2019-2024)
Table 26. Global Monoclonal Antibody Treatment Market Size (M USD) by Type (2019-2024)
Table 27. Global Monoclonal Antibody Treatment Market Size Share by Type (2019-2024)
Table 28. Global Monoclonal Antibody Treatment Price (USD/Ton) by Type (2019-2024)
Table 29. Global Monoclonal Antibody Treatment Sales (Kilotons) by Application
Table 30. Global Monoclonal Antibody Treatment Market Size by Application
Table 31. Global Monoclonal Antibody Treatment Sales by Application (2019-2024) & (Kilotons)
Table 32. Global Monoclonal Antibody Treatment Sales Market Share by Application (2019-2024)
Table 33. Global Monoclonal Antibody Treatment Sales by Application (2019-2024) & (M USD)
Table 34. Global Monoclonal Antibody Treatment Market Share by Application (2019-2024)
Table 35. Global Monoclonal Antibody Treatment Sales Growth Rate by Application (2019-2024)
Table 36. Global Monoclonal Antibody Treatment Sales by Region (2019-2024) & (Kilotons)
Table 37. Global Monoclonal Antibody Treatment Sales Market Share by Region (2019-2024)
Table 38. North America Monoclonal Antibody Treatment Sales by Country (2019-2024) & (Kilotons)
Table 39. Europe Monoclonal Antibody Treatment Sales by Country (2019-2024) & (Kilotons)
Table 40. Asia Pacific Monoclonal Antibody Treatment Sales by Region (2019-2024) & (Kilotons)
Table 41. South America Monoclonal Antibody Treatment Sales by Country (2019-2024) & (Kilotons)
Table 42. Middle East and Africa Monoclonal Antibody Treatment Sales by Region (2019-2024) & (Kilotons)
Table 43. Pfizer Monoclonal Antibody Treatment Basic Information
Table 44. Pfizer Monoclonal Antibody Treatment Product Overview
Table 45. Pfizer Monoclonal Antibody Treatment Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 46. Pfizer Business Overview
Table 47. Pfizer Monoclonal Antibody Treatment SWOT Analysis
Table 48. Pfizer Recent Developments
Table 49. Bayer Monoclonal Antibody Treatment Basic Information
Table 50. Bayer Monoclonal Antibody Treatment Product Overview
Table 51. Bayer Monoclonal Antibody Treatment Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 52. Bayer Business Overview
Table 53. Bayer Monoclonal Antibody Treatment SWOT Analysis
Table 54. Bayer Recent Developments
Table 55. Sanofi Monoclonal Antibody Treatment Basic Information
Table 56. Sanofi Monoclonal Antibody Treatment Product Overview
Table 57. Sanofi Monoclonal Antibody Treatment Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 58. Sanofi Monoclonal Antibody Treatment SWOT Analysis
Table 59. Sanofi Business Overview
Table 60. Sanofi Recent Developments
Table 61. Merck Monoclonal Antibody Treatment Basic Information
Table 62. Merck Monoclonal Antibody Treatment Product Overview
Table 63. Merck Monoclonal Antibody Treatment Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 64. Merck Business Overview
Table 65. Merck Recent Developments
Table 66. GlaxoSmithKline Monoclonal Antibody Treatment Basic Information
Table 67. GlaxoSmithKline Monoclonal Antibody Treatment Product Overview
Table 68. GlaxoSmithKline Monoclonal Antibody Treatment Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 69. GlaxoSmithKline Business Overview
Table 70. GlaxoSmithKline Recent Developments
Table 71. Roche Monoclonal Antibody Treatment Basic Information
Table 72. Roche Monoclonal Antibody Treatment Product Overview
Table 73. Roche Monoclonal Antibody Treatment Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 74. Roche Business Overview
Table 75. Roche Recent Developments
Table 76. Novartis Monoclonal Antibody Treatment Basic Information
Table 77. Novartis Monoclonal Antibody Treatment Product Overview
Table 78. Novartis Monoclonal Antibody Treatment Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 79. Novartis Business Overview
Table 80. Novartis Recent Developments
Table 81. AbbVie Monoclonal Antibody Treatment Basic Information
Table 82. AbbVie Monoclonal Antibody Treatment Product Overview
Table 83. AbbVie Monoclonal Antibody Treatment Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 84. AbbVie Business Overview
Table 85. AbbVie Recent Developments
Table 86. Shanghai Junshi Biosciences Co.,Ltd Monoclonal Antibody Treatment Basic Information
Table 87. Shanghai Junshi Biosciences Co.,Ltd Monoclonal Antibody Treatment Product Overview
Table 88. Shanghai Junshi Biosciences Co.,Ltd Monoclonal Antibody Treatment Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 89. Shanghai Junshi Biosciences Co.,Ltd Business Overview
Table 90. Shanghai Junshi Biosciences Co.,Ltd Recent Developments
Table 91. Innovent Biologics Monoclonal Antibody Treatment Basic Information
Table 92. Innovent Biologics Monoclonal Antibody Treatment Product Overview
Table 93. Innovent Biologics Monoclonal Antibody Treatment Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 94. Innovent Biologics Business Overview
Table 95. Innovent Biologics Recent Developments
Table 96. Jiangsu Hengrui Medicine Co.,Ltd. Monoclonal Antibody Treatment Basic Information
Table 97. Jiangsu Hengrui Medicine Co.,Ltd. Monoclonal Antibody Treatment Product Overview
Table 98. Jiangsu Hengrui Medicine Co.,Ltd. Monoclonal Antibody Treatment Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 99. Jiangsu Hengrui Medicine Co.,Ltd. Business Overview
Table 100. Jiangsu Hengrui Medicine Co.,Ltd. Recent Developments
Table 101. BeiGene, Ltd. Monoclonal Antibody Treatment Basic Information
Table 102. BeiGene, Ltd. Monoclonal Antibody Treatment Product Overview
Table 103. BeiGene, Ltd. Monoclonal Antibody Treatment Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 104. BeiGene, Ltd. Business Overview
Table 105. BeiGene, Ltd. Recent Developments
Table 106. Grand Pharmaceutical (China) Co., Ltd Monoclonal Antibody Treatment Basic Information
Table 107. Grand Pharmaceutical (China) Co., Ltd Monoclonal Antibody Treatment Product Overview
Table 108. Grand Pharmaceutical (China) Co., Ltd Monoclonal Antibody Treatment Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 109. Grand Pharmaceutical (China) Co., Ltd Business Overview
Table 110. Grand Pharmaceutical (China) Co., Ltd Recent Developments
Table 111. Henlius Monoclonal Antibody Treatment Basic Information
Table 112. Henlius Monoclonal Antibody Treatment Product Overview
Table 113. Henlius Monoclonal Antibody Treatment Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 114. Henlius Business Overview
Table 115. Henlius Recent Developments
Table 116. Global Monoclonal Antibody Treatment Sales Forecast by Region (2025-2030) & (Kilotons)
Table 117. Global Monoclonal Antibody Treatment Market Size Forecast by Region (2025-2030) & (M USD)
Table 118. North America Monoclonal Antibody Treatment Sales Forecast by Country (2025-2030) & (Kilotons)
Table 119. North America Monoclonal Antibody Treatment Market Size Forecast by Country (2025-2030) & (M USD)
Table 120. Europe Monoclonal Antibody Treatment Sales Forecast by Country (2025-2030) & (Kilotons)
Table 121. Europe Monoclonal Antibody Treatment Market Size Forecast by Country (2025-2030) & (M USD)
Table 122. Asia Pacific Monoclonal Antibody Treatment Sales Forecast by Region (2025-2030) & (Kilotons)
Table 123. Asia Pacific Monoclonal Antibody Treatment Market Size Forecast by Region (2025-2030) & (M USD)
Table 124. South America Monoclonal Antibody Treatment Sales Forecast by Country (2025-2030) & (Kilotons)
Table 125. South America Monoclonal Antibody Treatment Market Size Forecast by Country (2025-2030) & (M USD)
Table 126. Middle East and Africa Monoclonal Antibody Treatment Consumption Forecast by Country (2025-2030) & (Units)
Table 127. Middle East and Africa Monoclonal Antibody Treatment Market Size Forecast by Country (2025-2030) & (M USD)
Table 128. Global Monoclonal Antibody Treatment Sales Forecast by Type (2025-2030) & (Kilotons)
Table 129. Global Monoclonal Antibody Treatment Market Size Forecast by Type (2025-2030) & (M USD)
Table 130. Global Monoclonal Antibody Treatment Price Forecast by Type (2025-2030) & (USD/Ton)
Table 131. Global Monoclonal Antibody Treatment Sales (Kilotons) Forecast by Application (2025-2030)
Table 132. Global Monoclonal Antibody Treatment Market Size Forecast by Application (2025-2030) & (M USD)
List of Figures
Figure 1. Product Picture of Monoclonal Antibody Treatment
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Monoclonal Antibody Treatment Market Size (M USD), 2019-2030
Figure 5. Global Monoclonal Antibody Treatment Market Size (M USD) (2019-2030)
Figure 6. Global Monoclonal Antibody Treatment Sales (Kilotons) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Monoclonal Antibody Treatment Market Size by Country (M USD)
Figure 11. Monoclonal Antibody Treatment Sales Share by Manufacturers in 2023
Figure 12. Global Monoclonal Antibody Treatment Revenue Share by Manufacturers in 2023
Figure 13. Monoclonal Antibody Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Monoclonal Antibody Treatment Average Price (USD/Ton) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Monoclonal Antibody Treatment Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Monoclonal Antibody Treatment Market Share by Type
Figure 18. Sales Market Share of Monoclonal Antibody Treatment by Type (2019-2024)
Figure 19. Sales Market Share of Monoclonal Antibody Treatment by Type in 2023
Figure 20. Market Size Share of Monoclonal Antibody Treatment by Type (2019-2024)
Figure 21. Market Size Market Share of Monoclonal Antibody Treatment by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Monoclonal Antibody Treatment Market Share by Application
Figure 24. Global Monoclonal Antibody Treatment Sales Market Share by Application (2019-2024)
Figure 25. Global Monoclonal Antibody Treatment Sales Market Share by Application in 2023
Figure 26. Global Monoclonal Antibody Treatment Market Share by Application (2019-2024)
Figure 27. Global Monoclonal Antibody Treatment Market Share by Application in 2023
Figure 28. Global Monoclonal Antibody Treatment Sales Growth Rate by Application (2019-2024)
Figure 29. Global Monoclonal Antibody Treatment Sales Market Share by Region (2019-2024)
Figure 30. North America Monoclonal Antibody Treatment Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 31. North America Monoclonal Antibody Treatment Sales Market Share by Country in 2023
Figure 32. U.S. Monoclonal Antibody Treatment Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 33. Canada Monoclonal Antibody Treatment Sales (Kilotons) and Growth Rate (2019-2024)
Figure 34. Mexico Monoclonal Antibody Treatment Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Monoclonal Antibody Treatment Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 36. Europe Monoclonal Antibody Treatment Sales Market Share by Country in 2023
Figure 37. Germany Monoclonal Antibody Treatment Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 38. France Monoclonal Antibody Treatment Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 39. U.K. Monoclonal Antibody Treatment Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 40. Italy Monoclonal Antibody Treatment Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 41. Russia Monoclonal Antibody Treatment Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 42. Asia Pacific Monoclonal Antibody Treatment Sales and Growth Rate (Kilotons)
Figure 43. Asia Pacific Monoclonal Antibody Treatment Sales Market Share by Region in 2023
Figure 44. China Monoclonal Antibody Treatment Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 45. Japan Monoclonal Antibody Treatment Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 46. South Korea Monoclonal Antibody Treatment Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 47. India Monoclonal Antibody Treatment Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 48. Southeast Asia Monoclonal Antibody Treatment Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 49. South America Monoclonal Antibody Treatment Sales and Growth Rate (Kilotons)
Figure 50. South America Monoclonal Antibody Treatment Sales Market Share by Country in 2023
Figure 51. Brazil Monoclonal Antibody Treatment Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 52. Argentina Monoclonal Antibody Treatment Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 53. Columbia Monoclonal Antibody Treatment Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 54. Middle East and Africa Monoclonal Antibody Treatment Sales and Growth Rate (Kilotons)
Figure 55. Middle East and Africa Monoclonal Antibody Treatment Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Monoclonal Antibody Treatment Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 57. UAE Monoclonal Antibody Treatment Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 58. Egypt Monoclonal Antibody Treatment Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 59. Nigeria Monoclonal Antibody Treatment Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 60. South Africa Monoclonal Antibody Treatment Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 61. Global Monoclonal Antibody Treatment Sales Forecast by Volume (2019-2030) & (Kilotons)
Figure 62. Global Monoclonal Antibody Treatment Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Monoclonal Antibody Treatment Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Monoclonal Antibody Treatment Market Share Forecast by Type (2025-2030)
Figure 65. Global Monoclonal Antibody Treatment Sales Forecast by Application (2025-2030)
Figure 66. Global Monoclonal Antibody Treatment Market Share Forecast by Application (2025-2030)
